Literature DB >> 26999396

Bacterial Evasion of Host Antimicrobial Peptide Defenses.

Jason N Cole1,2,3, Victor Nizet1,4,5.   

Abstract

Antimicrobial peptides (AMPs), also known as host defense peptides, are small naturally occurring microbicidal molecules produced by the host innate immune response that function as a first line of defense to kill pathogenic microorganisms by inducing deleterious cell membrane damage. AMPs also possess signaling and chemoattractant activities and can modulate the innate immune response to enhance protective immunity or suppress inflammation. Human pathogens have evolved defense molecules and strategies to counter and survive the AMPs released by host immune cells such as neutrophils and macrophages. Here, we review the various mechanisms used by human bacterial pathogens to resist AMP-mediated killing, including surface charge modification, active efflux, alteration of membrane fluidity, inactivation by proteolytic digestion, and entrapment by surface proteins and polysaccharides. Enhanced understanding of AMP resistance at the molecular level may offer insight into the mechanisms of bacterial pathogenesis and augment the discovery of novel therapeutic targets and drug design for the treatment of recalcitrant multidrug-resistant bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26999396      PMCID: PMC4804471          DOI: 10.1128/microbiolspec.VMBF-0006-2015

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  281 in total

1.  Therapeutic antimicrobial peptides may compromise natural immunity.

Authors:  Michelle G J L Habets; Michael A Brockhurst
Journal:  Biol Lett       Date:  2012-01-25       Impact factor: 3.703

2.  Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity.

Authors:  R P Darveau; J Blake; C L Seachord; W L Cosand; M D Cunningham; L Cassiano-Clough; G Maloney
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection.

Authors:  Cheryl Y M Okumura; Andrew Hollands; Dan N Tran; Joshua Olson; Samira Dahesh; Maren von Köckritz-Blickwede; Wdee Thienphrapa; Courtney Corle; Seung Nam Jeung; Anna Kotsakis; Robert A Shalwitz; Randall S Johnson; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2012-02-28       Impact factor: 4.599

4.  The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design.

Authors:  Nina M van Sorge; Jason N Cole; Kirsten Kuipers; Anna Henningham; Ramy K Aziz; Ana Kasirer-Friede; Leo Lin; Evelien T M Berends; Mark R Davies; Gordon Dougan; Fan Zhang; Samira Dahesh; Laura Shaw; Jennifer Gin; Madeleine Cunningham; Joseph A Merriman; Julia Hütter; Bernd Lepenies; Suzan H M Rooijakkers; Richard Malley; Mark J Walker; Sanford J Shattil; Patrick M Schlievert; Biswa Choudhury; Victor Nizet
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

5.  Teichoic acids and membrane function in bacteria.

Authors:  S Heptinstall; A R Archibald; J Baddiley
Journal:  Nature       Date:  1970-02-07       Impact factor: 49.962

6.  Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells.

Authors:  F Niyonsaba; A Someya; M Hirata; H Ogawa; I Nagaoka
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

7.  Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant.

Authors:  Kahori Kurosaka; Qian Chen; Felix Yarovinsky; Joost J Oppenheim; De Yang
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

8.  The dlt operon of Bacillus cereus is required for resistance to cationic antimicrobial peptides and for virulence in insects.

Authors:  Z Abi Khattar; A Rejasse; D Destoumieux-Garzón; J M Escoubas; V Sanchis; D Lereclus; A Givaudan; M Kallassy; C Nielsen-Leroux; S Gaudriault
Journal:  J Bacteriol       Date:  2009-09-18       Impact factor: 3.490

9.  An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.

Authors:  Rembert Koczulla; Georges von Degenfeld; Christian Kupatt; Florian Krötz; Stefan Zahler; Torsten Gloe; Katja Issbrücker; Pia Unterberger; Mohamed Zaiou; Corinna Lebherz; Alexander Karl; Philip Raake; Achim Pfosser; Peter Boekstegers; Ulrich Welsch; Pieter S Hiemstra; Claus Vogelmeier; Richard L Gallo; Matthias Clauss; Robert Bals
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Nuclease A (Gbs0661), an extracellular nuclease of Streptococcus agalactiae, attacks the neutrophil extracellular traps and is needed for full virulence.

Authors:  Aurélie Derré-Bobillot; Naima G Cortes-Perez; Yuji Yamamoto; Pascale Kharrat; Elizabeth Couvé; Violette Da Cunha; Patrice Decker; Marie-Christophe Boissier; Frédéric Escartin; Bénédicte Cesselin; Philippe Langella; Luis G Bermúdez-Humarán; Philippe Gaudu
Journal:  Mol Microbiol       Date:  2013-07-05       Impact factor: 3.501

View more
  34 in total

Review 1.  Evolutionary and ecological forces that shape the bacterial communities of the human gut.

Authors:  J S Messer; E R Liechty; O A Vogel; E B Chang
Journal:  Mucosal Immunol       Date:  2017-02-01       Impact factor: 7.313

Review 2.  Perspectives on the evolutionary ecology of arthropod antimicrobial peptides.

Authors:  Jens Rolff; Paul Schmid-Hempel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

3.  Dead bacterial absorption of antimicrobial peptides underlies collective tolerance.

Authors:  Fan Wu; Cheemeng Tan
Journal:  J R Soc Interface       Date:  2019-02-28       Impact factor: 4.118

Review 4.  Antimicrobial Peptides: Mechanisms of Action and Resistance.

Authors:  B Bechinger; S-U Gorr
Journal:  J Dent Res       Date:  2016-11-25       Impact factor: 6.116

5.  Mycoplasma hyopneumoniae Inhibits Porcine Beta-Defensin 2 Production by Blocking the Unfolded Protein Response To Facilitate Epithelial Adhesion and Infection.

Authors:  Qiao Pan; Xiumei Wang; Tong Liu; Ying Yu; Lu Li; Rui Zhou; Ganwu Li; Jiuqing Xin
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

6.  The Opp (AmiACDEF) Oligopeptide Transporter Mediates Resistance of Serotype 2 Streptococcus pneumoniae D39 to Killing by Chemokine CXCL10 and Other Antimicrobial Peptides.

Authors:  Kevin E Bruce; Britta E Rued; Ho-Ching Tiffany Tsui; Malcolm E Winkler
Journal:  J Bacteriol       Date:  2018-05-09       Impact factor: 3.490

7.  UPR modulation of host immunity by Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Brahmchetna Bedi; Kuo-Chuan Lin; Nicholas M Maurice; Zhihong Yuan; Kaiser Bijli; Michael Koval; C Michael Hart; Joanna B Goldberg; Arlene Stecenko; Ruxana T Sadikot
Journal:  Clin Sci (Lond)       Date:  2020-07-31       Impact factor: 6.124

8.  Ubiquitously expressed Human Beta Defensin 1 (hBD1) forms bacteria-entrapping nets in a redox dependent mode of action.

Authors:  Judith Raschig; Daniela Mailänder-Sánchez; Anne Berscheid; Jürgen Berger; Adam A Strömstedt; Lioba F Courth; Nisar P Malek; Heike Brötz-Oesterhelt; Jan Wehkamp
Journal:  PLoS Pathog       Date:  2017-03-21       Impact factor: 6.823

9.  Cathelicidin-deficient mice exhibit increased survival and upregulation of key inflammatory response genes following cecal ligation and puncture.

Authors:  Patricia Severino; Suely Kubo Ariga; Hermes Vieira Barbeiro; Thais Martins de Lima; Elisangela de Paula Silva; Denise Frediani Barbeiro; Marcel Cerqueira César Machado; Victor Nizet; Fabiano Pinheiro da Silva
Journal:  J Mol Med (Berl)       Date:  2017-06-16       Impact factor: 4.599

10.  DNA Blocks the Lethal Effect of Human Beta-Defensin 2 Against Neisseria meningitidis.

Authors:  Gabriela M Wassing; Kenny Lidberg; Sara Sigurlásdóttir; Jonas Frey; Kristen Schroeder; Nathalie Ilehag; Ann-Christin Lindås; Kristina Jonas; Ann-Beth Jonsson
Journal:  Front Microbiol       Date:  2021-06-30       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.